Methylphenidate Hydrochloride 72865-0133
Product NDC
72865-0133- Manufacturer
- Xlcare Pharmaceuticals, Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- February 24, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA211009
Active Ingredients
| Ingredient | Strength |
|---|---|
| Methylphenidate Hydrochloride | 18 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Packaging Options(1)
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-133-01)